ClinicalTrials.Veeva

Menu

Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Chronic Heart Failure
Coronary Disease
Dilated Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT01139086
201003050R

Details and patient eligibility

About

Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment was the major cause of clinical symptoms, and mechanism may be related to neuroendocrine impairment and vascular smooth muscle dysfunction. It results in increased peripheral resistance that may influence limb blood flow, muscle fitness and activities of daily.The purposes of this study are

  1. to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living
  2. to compare endothelium function between CHF patients and healthy control subjects
  3. the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.

Enrollment

100 estimated patients

Sex

Male

Ages

40 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 40-75 years
  • Chronic heart failure: ejection fraction<40% and at stable condition
  • Coronary Disease and dilated cardiomyopathy without heart failure
  • Control group without diagnosis of any heart disease

Exclusion criteria

  • Clinical diagnosis of neuromusculoskeletal , pulmonary, or other systemic diseases that may affect the testing of the study

Trial design

100 participants in 3 patient groups

Cardiovascular disease
Description:
Diagnosis of cardiomyopathy or ischemic heart disease without heart failure
Chronic heart failure
Description:
Diagnosis of cardiomyopathy or ischemic heart disease LVEF \<40%
Control
Description:
Age and body built matched with chronic heart failure group

Trial contacts and locations

1

Loading...

Central trial contact

Ying-Tai Wu, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems